Posted by Sue Smith on Mar 07, 2023

The Peter Doherty Institute for Infection and Immunity is conducting a study of an experimental influenza (flu) vaccine using new mRNA technology and is seeking healthy adults 65 years and older.  

The safety and ability of the new vaccine to promote a protective immune response is being compared to existing licensed flu vaccines.  
We are looking for participants who are: 
- Aged 65 years and older 
- In good health 
The study includes receiving one vaccine, as well as having blood samples taken and follow-up for approximately 12 months.  
You will be reimbursed for your travel and time on the study.  
For more information and to volunteer, please contact: 
• Email  
• Phone 8344-9325 

The Doherty Institute is named in honour of Patron, Laureate Professor Peter Doherty, winner of the 1996 Nobel Prize in Physiology or Medicine for discovering how the immune system recognises virus-infected cells. Under the expert guidance of Director, University of Melbourne Professor Sharon Lewin, a leader in research and clinical management of HIV and infectious diseases, the Doherty Institute has more than 700 staff who work on infection and immunity through a broad spectrum of activities. This includes discovery research; diagnosis, surveillance and investigation of infectious disease outbreaks; and the development of ways to prevent, treat and eliminate infectious diseases. Website: